Skip to main content
. 2014 Jun;35(6):1124–1131. doi: 10.3174/ajnr.A3819

Table 1:

Clinical summary of 175 adult patients with Moyamoya disease with acute ischemic or hemorrhagic stroke

Variables Total (n = 175) Infarct group (n = 79) Hemorrhage Group (n = 96) P Value
Demographics
    Age, y (mean ± SD) 42.2 ± 11.3 41.2 ± 11.2 43.1 ± 11.3 .28
    Female 107 (61.1) 46 (58.2) 61 (63.5) .47
Family history 1 (0.6) 1 (1.3) 0 .45
Vascular risk factors
    Hypertension 44 (25.1) 22 (27.8) 22 (22.9) .45
    Diabetes 20 (11.4) 14 (17.7) 6 (6.3) .018
Symptoms
    Headache 52 (29.7) 14 (17.7) 38 (39.6) .002
    Weakness 71 (40.6) 33 (41.8) 38 (39.6) .76
    Sensory change 9 (5.1) 8 (10.1) 1 (1.0) .012
    Speech disturbance 41 (23.4) 30 (38.0) 11 (11.5) <.001
    Visual disturbance 16 (9.1) 15 (19.0) 1 (1.0) <.001
    Seizure 5 (2.9) 1 (1.3) 4 (4.2) .38
    Decreased consciousness 62 (35.4) 4 (5.1) 58 (60.4) <.001
Initial neurology
    Initial GCS (>12) 133 (76.0) 78 (98.7) 55 (57.3) <.001
    Initial mRS (<3) 100 (57.1) 55 (69.6) 45 (46.9) .002
Suzuki stage (350 hemispheres) .061
    1 29 (8.3) 19 (12.0) 10 (5.2)
    2 87 (24.9) 46 (29.1) 41 (21.4)
    3 137 (39.1) 53 (33.5) 84 (43.8)
    4 65 (18.6) 26 (16.5) 39 (20.3)
    5 29 (8.3) 13 (8.2) 16 (8.3)
    6 3 (0.9) 1 (0.6) 2 (1.0)

Note:—SD indicates standard deviation; GCS, Glasgow Coma Scale.